Proton MRS of large multiple sclerosis lesions reveals subtle changes in metabolite T1 and area
Authors:
- 19 May 2010
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 23 (9) , 1033-1037
Abstract
The T1 values of metabolites were measured in eight subjects with clinically definite multiple sclerosis (MS) having at least one large brain lesion (2.6 ± 0.7 mL) and in eight age‐ and sex‐matched healthy controls. MRS examinations were conducted at 1.5 T using point‐resolved spectroscopy (PRESS) (TE = 30 ms, TR = 530, 750, 1200, 1500, 3500, 5000 ms). Spectra were acquired from a voxel placed in the largest lesion in the subject with MS, and in a corresponding voxel (same size and region) in normal white matter (NWM) in the matched control, and were fitted using LCModel. As there are regional variations in metabolite and water T1 and metabolite signal areas, careful placement of the control voxel was necessary to measure subtle differences between the lesions and NWM. The T1 and T1‐corrected signal areas of creatine were the same in MS lesions as in controls. The T1 values of choline were significantly shorter in MS lesions located in occipital and parietal, but not in frontal, white matter. N‐Acetylaspartate (NAA) and myoinositol T1 values in MS lesions were similar to those in NWM; however, the area of myoinositol correlated directly with lesion water T1, and the area of NAA correlated inversely with lesion water T1. MR spectra acquired at short TR require T1 correction of choline for accurate quantification. Careful voxel placement in controls to match lesion location in subjects with MS enables a clearer view of the subtle changes in lesions. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosisMagnetic Resonance in Medicine, 2006
- 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic reviewBrain, 2005
- Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H—magnetic resonance spectroscopyJournal of Neurology, 2005
- Choline is increased in pre-lesional normal appearing white matter in multiple sclerosisJournal of Neurology, 2002
- Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)‐induced experimental demyelinating lesion modelNMR in Biomedicine, 2002
- Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy studyJournal of the Neurological Sciences, 2001
- Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosisNMR in Biomedicine, 2000
- Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosisAnnals of Neurology, 1998
- Chemical pathology of acute demyelinating lesions and its correlation with disabilityAnnals of Neurology, 1995
- The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratioMagnetic Resonance in Medicine, 1993